The company announced encouraging clinical trial data for its experimental cell therapy, AUTO1.Shares of Autolus Therapeutics (NASDAQ: AUTL) were trading 35% higher as of 3:37 p.m. EDT on Wednesday. Those big gains came after the company announced that its experimental CD19 cell therapy, AUTO1, had ...

https://www.fool.com/investing/2021/05/12/why-autolus-therapeutics-stock-skyrocketed-today/?source=iedfolrf0000001

#fool